Eliminating Type 1 Diabetes: The XOStem Breakthrough

Welcome to XOStem! In this video, XOStem Biosciences introduces their groundbreaking work in the field of Type 1 diabetes treatment. Led by Dr. Jonathan Lakey, the Chief Scientific Officer, along with Dr. Reza Mohammadi, the Chief Scientific Advisor, and Brad Eckenweiler, the CEO of XOStem Inc., they are on a mission to eliminate Type 1 diabetes. Through their innovative encapsulated islet transplantation therapy, they aim to overcome the limitations of previous approaches and provide a long-term, cost-effective solution for every Type 1 diabetic patient. Together, let's revolutionize the treatment of Type 1 diabetes.
www.xostem.com/